Recent work in both animal and human studies emphasizes the value of magnesium in the maintenance of the functional and structural integrity of cardiac muscle. Both intracellular and extracellular magnesium concentrations can vary independently and the serum and red cell magnesium levels may not give an accurate acconnt of intracellular cardiac magnesium deficiency. However, electrocardiographic studies of magnesium levels could provide an accurate index of intracellular cardiac magnesium levels.
and 0.43 seconds in women. 1~ A prolonged QT~ interval results from delayed repolarization of the ventricular myocardium. It is during this period that the patient is highly vulnerable to cardiac arrhythmias with myocardial infarction and death.~. It has been predicted that certain individuals with congenitally prolonged QT~ intervals are at increased risk of fatal ventricular fibrillation when conditions causing hypoxia or sympathetic discharge occur ~6 Based on measurement of the QTc intervals and clinical observations during magnesium therapy for anxiety states, it it was decided to study the effects of slow releasing oral magnesium chloride on the electrocardiogram during cardiopulmonary bypass procedures.
METHODS
Twenty-four patients ranging in age from 14 to 58 years scheduled electively for mitral valve replacement utilizing cardiopulmonary bypass were selected to participate in the study. All patients had been using some type of diuretic agent and had been digitalized for at least two months before operation. All patients had not 329 been taking magnesium-containing drugs for the same period of time. it was not necessary to administer diuretics or to digitialize any of the patients during the immediate preoperative period. Informed consent and institutional approval were obtained for all patients participating in the investigation. Upon hospitalization baseline electrocardiographic studies and a full blood count were done, and serum electrolytes were determined on all 24 patients. The rate and rhythm of all preoperative electrocardiographic tracings were normal. The average preoperative QT~ interval of the electrocardiogram for all patients was 0.425 seconds with a standard deviation of 0.025 seconds. The patients were then randomly assigned to one of two treatment arms: Group I (treatment): patients who received oral magnesium tablets for four days preoperatively. Each tablet contained 535 mg MgCI2.6H20. The oral dosage was 80mg per kilogram body weight. Group II (control): patients who received oral placebo tablets identical in size, shape, and colour to the magnesium chloride tables. The tablets were administered to the patients from coded bottles by the nursing staff and at the beginning of the fifth day, open heart surgery was done. All patients were premedicated using morphine 0. l mg-kg -n and atropine 0.05 rag. kg -t. Anaesthesia was induced using thiopentone sodium and neuromuscular blockade attained using succinylcholine 1.5 mg. kg -~. Following tracheal intubation ventilation was controlled to maintain Paco2 of 4.66-5.32 kPa (35-40torr). Anaesthesia was maintained with a mixture of nitrous oxide and oxygen (50:50), pancuronium 0.1 mg-kg -I and morphine sulphate 0.15 rag-kg -~ increments intravenously.
During cardiopulmonary bypass the composition of the pump priming solution was two units of fresh blood and one unit of plasmalyte B (1000 ml). Plasmalyte B is a balanced solution of electrolytes containing sodium 130mmol per litre, potassium 4retool per litre, bicarbonate 28 mmol per litre, and the pH of solution is 7.4.
The exact composition of cardioplegic solution was the same in all cases and consisted of 1000 ml of plasmalyte B to which was added 30retool potassium, 16ml 50 per cent dextrose, 2.5ml sodium bicarbonate 8.4% solution, 1.0ml calcium chloride 10% solution, 500 mg solumedrol. The osmolarity of the solution was approximately 330 and the pH was 7.38. All patients were cooled to 28~ during bypass.
Immediately after operation electrocardiographic studies were made and the QTc intervals were measured for four consecutive postoperative days. Any arrhythmias that occurred during the postoperative phases were also noted and recorded. Groups I and II were compared for the average per patient change in QT~ interval from initial admission to the time just before the operation four days later, using a paired t-test. The comparison of postoperative QTr interval changes was done using repeated measure analysis of variance techniques. Finally, if enough arrhythmias occurred during the trial, a comparison of this subgroup of patients with the arrhythmia-free group of patients was made.
RESULTS
After the allocation of patients to Group I (treatment) and Group II (control) was made, average pretreatment QTc intervals _ one standard deviation were: Group 1:0.428 + 0.026 and Group II: 0.422 + 0.024. These were not significantly different.
At the end of the four day preoperative treatment, those patients on oral magnesium chloride had an average decrease in QTc interval of 0.0279 seconds. The untreated control patients had an average increase in QTc interval of + 0.0076 seconds. This difference in the average change was statistically significant (t = 7. L5 p < 0.001). (Figure I ).
During the postoperative phase of the trial, all patients had a similar pattern of a rise in the QTc interval during the first two postoperative days, followed by a decrease in the last two days of observation. This pattern is shown in Figure l , and can be represented mathematically by a quadratic function. Using least squares a quadratic equation was fitted to both the treated groups and to the control group. A plot of the two fitted equations shows them parallel, with the distance between them indicating the effect of oral magnesium chloride priming on the QT~ interval. This difference was 0.0293 seconds QT~ interval less for the treated group during the four postoperative days. This was statistically significant (p < 0.01). Figure 2 shows the patterns in QTc intervals for the two control groups and the treated group. Again, the patterns are almost identical and the same general quadratic function described previously holds here as well. Thus, once the preoperative QTc level has been established, the Five patients developed arrhythmias postoperatively. Three developed ventricu[ar extrasystoles, one a bigeminal rhythm and one paroxysmal atrial tachycardia. All five of these patients were on the control arm of the trial. Retrospectively, a re-analysis of the data was done by dividing Group II (control) into two groups, controls with dysrhythmias and controls without dysrhythmias. Table I shows the preoperative changes in QT,. intervals for all three groups (the two control groups and the treated groups). While the change in QTe interval was larger for those in the control who developed DYS; i.e. + 0.0132, compared to those in the control who did not develop DYS; i.e. --0.0036, statistically they were not significantly different (t = 1.38, p> 0.15).
DISCUSSION
Magnesium is involved in normal mitochondrial contraction with the formation of the magnesium-ATP complex which is the true substrate for all reactions involving ATP '4. Magriesium also affects the sodium-potassium ATPase of heart membranes, and activates adenyl cyclase in heart muscle. '~ With depletion of cardiac magnesium as a result of ischaemia, anoxia or the administration of cardiotoxic drugs, ATPase becomes inactivated and oxidative phosphorylation is inhibited. Cellular potassium efflux and sodium influx takes place and mitochondrial swelling occurs, ultimately resulting in myocardial fibre necrosis, ll-13 Magnesium is thus vital in the maintenance of mitochondrial integrity and in the retention of myocardial potassium. Several factors may contribute to the postoperative fall in magnesium levels and the development of arrhythmias in patients undergoing open heart surgery using cardiopulmonary bypass. These include a preoperative magnesium deficiency in patients with cardiac pathology, anaesthesia using artificial ventilation with hyperventilation, haemodilution, acid-base disturbances, duration of perfusion, and the use of drugs. The careful monitoring of intracellular magnesium levels is thus of prime importance. The serum and red cell magnesium levels may not be an accurate reflection of intracellular cardiac magnesium deficiency. However, electrocardiographic studies could provide an accurate index of intracellular cardiac magnesium levels and can be a valuable way of detecting changes in the electrophysiological events in the myocardium during magnesium deficiency and magnesium therapy. The effect of an enteric-coated slow releasing oral tablet of magnesium chloride on the QTc interval during open heart surgery was interesting statistically. Although pretreatment QT~ values were not significantly different, there was a highly significant difference between the treatment and control groups following four days of oral magnesium chloride treatment in the preoperative period. It was also very interesting to note that during the postoperative phase of the trial, all patients developed a similar pattern of a rise in the QTr interval, reaching a peak at the end of the second day, followed by a decrease over the next two days. Finally, it should be noted that all five patients who developed arrhythmias postoperatively had not been pretreated (primed) with oral magnesium chloride and that those patients had an abnormal QT~ interval both before and after operation.
The results of this study demonstrate the use of oral magnesium chloride in reducing the QTe interval of the electrocardiogram and so protecting the myocardium against possible arrhythmias. The potential of prophylactic use of oral magnesium in heart disease is illustrated.
